Drug intelligence / Profile preview

Leuclear

Development stage: Unknown
Lead developer: Kee Pharma
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral, Vaginal

Overview

**Leuclear** is a Kee Pharma nutraceutical and herbal women’s-health product marketed for relief of leucorrhoea, including physiological, inflammatory, and parasitic leucorrhoea. It is supplied as oral capsules and vaginal suppositories containing a heterogeneous 12-ingredient herbal formulation: Hadjod, Ashoka, Lodhra, Goolar, Satavari, Dhawai, Seva, Dashmool, Shilajit, Neem, Mulethi, and Pipli. Kee Pharma markets the product with antimicrobial, antifungal, analgesic, anti-inflammatory, and hormone-balancing claims; however, no defined molecular target, standardized active constituent, or clinical-development evidence was identified.

Brand names: Leuclear

Beyond the preview

Go deeper on Leuclear.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leuclear.

Explore the full profile